Buchumschlag

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Coghill, David (BerichterstatterIn) , Banaschewski, Tobias (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: European neuropsychopharmacology
Year: 2013, Jahrgang: 23, Heft: 10, Pages: 1208-1218
ISSN:1873-7862
Online-Zugang:Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0924977X12003240
Volltext
Verfasserangaben:Coghill, David; Banaschewski, Tobias ...

MARC

LEADER 00000caa a22000002c 4500
001 1480255343
003 DE-627
005 20220811101456.0
007 cr uuu---uuuuu
008 140730s2013 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.euroneuro.2012.11.012  |2 doi 
035 |a (DE-627)1480255343 
035 |a (DE-576)410255343 
035 |a (DE-599)BSZ410255343 
035 |a (OCoLC)1340643610 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder  |c Coghill, David; Banaschewski, Tobias ... 
264 1 |c 2013 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 30.07.2014 
700 1 |a Coghill, David  |0 (DE-588)1056994487  |0 (DE-627)795032463  |0 (DE-576)314253319  |4 oth 
700 1 |a Banaschewski, Tobias  |d 1961-  |0 (DE-588)115856110  |0 (DE-627)507227301  |0 (DE-576)178364703  |4 oth 
773 0 8 |i In  |t European neuropsychopharmacology  |d Amsterdam : Elsevier, 1990  |g 23(2013), 10, Seite 1208-1218  |h Online-Ressource  |w (DE-627)320594025  |w (DE-600)2019305-1  |w (DE-576)266224334  |x 1873-7862  |7 nnas  |a European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder 
773 1 8 |g volume:23  |g year:2013  |g number:10  |g pages:1208-1218  |g extent:11  |a European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0924977X12003240  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20140730 
993 |a Article 
994 |a 2013 
998 |g 115856110  |a Banaschewski, Tobias  |m 115856110:Banaschewski, Tobias  |d 60000  |e 60000PB115856110  |k 0/60000/  |p 2 
999 |a KXP-PPN1480255343  |e 2810167370 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.euroneuro.2012.11.012"],"eki":["1480255343"]},"note":["Gesehen am: 30.07.2014"],"physDesc":[{"extent":"11 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2019305-1"],"eki":["320594025"],"issn":["1873-7862"]},"recId":"320594025","part":{"volume":"23","text":"23(2013), 10, Seite 1208-1218","extent":"11","issue":"10","pages":"1208-1218","year":"2013"},"disp":"European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorderEuropean neuropsychopharmacology","title":[{"title_sort":"European neuropsychopharmacology","subtitle":"ENP ; the journal of the European College of Neuropsychopharmacology","title":"European neuropsychopharmacology"}],"titleAlt":[{"title":"ENP"}],"note":["Gesehen am 31.01.20"],"language":["eng"],"pubHistory":["1.1990/91 -"],"origin":[{"dateIssuedDisp":"1990-","publisher":"Elsevier","dateIssuedKey":"1990","publisherPlace":"Amsterdam"}],"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"role":"oth","display":"Coghill, David","family":"Coghill","given":"David"},{"display":"Banaschewski, Tobias","given":"Tobias","family":"Banaschewski","role":"oth"}],"name":{"displayForm":["Coghill, David; Banaschewski, Tobias ..."]},"recId":"1480255343","title":[{"title_sort":"European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder","title":"European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder"}],"language":["eng"],"origin":[{"dateIssuedDisp":"2013","dateIssuedKey":"2013"}]} 
SRT |a EUROPEANRA2013 

Ähnliche Einträge